The stock price for Ventyx Biosciences Inc. (VTYX) currently stands at $33.45. The stock experienced a substantial increase in the last session, hitting $35.87 after starting at $35.87. The stock’s lowest price was $33.39 before closing at $35.92.
In terms of market performance, Ventyx Biosciences Inc. had a fairly even. The highest value for the stock in the past year was $47.25 on 03/03/23, and the lowest value was recorded at $11.07 on 06/29/22.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
52-week price history of VTYX Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Ventyx Biosciences Inc.’s current trading price is -29.21% away from its 52-week high, while its distance from the 52-week low is 202.17%. The stock’s price range during this period has spanned from $11.07 to $47.25. In the Healthcare sector, the Ventyx Biosciences Inc.’s shares surpassed a trading volume of approximately 0.58 million for the day, which was noticeably lower compared to the average daily volume of 9.0.86 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Ventyx Biosciences Inc. (VTYX) has experienced a quarterly decline of -21.66% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.90B and boasts a workforce of 76 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 37.46, with a change in price of +0.66. Similarly, Ventyx Biosciences Inc. recorded 789,968 in trading volume during the last 100 days, posting a change of +2.01%.
Examining VTYX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for VTYX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
VTYX Stock Stochastic Average
Today, Ventyx Biosciences Inc.’s raw stochastic average for the past 50 days stands at 43.02%, indicating a rise from the raw stochastic average of the last 20 days, which was 5.36%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 32.03% and 36.62% respectively.
VTYX Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 2.01%. However, over the past six months, we’ve seen a weaker performance of 24.26%. The price of VTYX leaped by -8.73% over the last 30 days. And in the last five days, it has fallen by -0.33%.